Mergers & Acquisitions

Found 19,155 articles

• Alberta Biophotonics Inc. Acquires Additional Shares of Flurotech Ltd. Pursuant to Amalgamation

  6/2/2021

  Prior to the Transaction, ABP held 16,417,500 Shares, representing 20.54% of FluroTech's 79,905,181 issued and outstanding Shares.

• The Generate Life Sciences Family of Companies Grows With the Addition of the Cell Care Group of Cord Blood Banks

  6/2/2021

  Generate Life Sciences (Generate) today announced that it has acquired the Cell Care international cord blood banking group (Cell Care), which comprises Cell Care in Australia, along with Insception Lifebank and Cells for Life in Canada.* Cell Care joins Generate's Cord Blood Registry in creating a global network of newborn stem cell (umbilical cord blood and tissue

• Quest Diagnostics Completes Acquisition of Mercy's Outreach Laboratory Services Business

  6/1/2021

  Quest Diagnostics (NYSE:DGX) and Mercy today announced that Quest has completed its previously announced acquisition of the outreach laboratory services business of Mercy in an all-cash asset transaction

•  Abiomed Acquires preCARDIA, a Breakthrough Medical Device Company, to Improve Outcomes for Heart Failure Patients

  6/1/2021

    Abiomed Acquires preCARDIA, a Breakthrough Medical Device Company, to Improve Outcomes for Heart Failure Patients

• GTCR-Backed Resonetics Acquires Distal Solutions

  6/1/2021

  GTCR, a leading private equity firm, announced today that Resonetics has completed an acquisition of Distal Solutions.

• Veracyte to Acquire HalioDx, Positioning for Global Cancer Diagnostics Growth

  6/1/2021

  Veracyte, Inc. announced it has reached the terms of an agreement to acquire HalioDx in a transaction to further accelerate growth and strengthen Veracyte’s global leadership in cancer diagnostics.

• Precision NanoSystems joins Danaher's Life Sciences Platform

  6/1/2021

  Precision NanoSystems (PNI) has been acquired by Danaher Corporation's Life Sciences platform. PNI is a global leader in technologies and solutions for the development of genetic medicines, including mRNA vaccines and therapeutics.

• Avantor® Acquires RIM Bio; Expands Bioproduction Footprint into China

  6/1/2021

  Avantor, Inc., a leading global provider of mission-critical products and services to customers in the life sciences, advanced technologies and applied materials industries, announced that it has acquired RIM Bio, a leading China-based manufacturer of single-use bioprocess bags and assemblies for biopharmaceutical manufacturing applications.

• Paragon 28®, Inc. Acquires the Assets of Additive Orthopaedics

  6/1/2021

  The Additive Orthopaedics acquisition includes FDA Approved, First in the World 3D-printed Patient Specific Talus Spacer for the Treatment of Avascular Necrosis for Humanitarian Use

• Newly Acquired VitalHub Subsidiary S12 Solutions Reports Recent Sales Since February 2021

  5/31/2021

  VITALHUB CORP. is pleased to report that newly acquired subsidiary, S12 Solutions, has achieved significant market penetration since February 2021.

• Nexturn Bio Inc. acquired a 50% stake in RosVivo Therapeutics, Inc.

  5/30/2021

  Nexturn Bio Inc., a subsidiary of Nexturn Bioscience Co., Ltd., announced on May 26th that it had acquired a 50% stake in RosVivo Therapeutics Inc., an American new drug developer, for about 5.5 million U.S. dollars.

• Accelerator Life Science Partners’ Portfolio Company Lodo Therapeutics Acquired by Zymergen Inc.

  5/28/2021

  Accelerator Life Science Partners (“ALSP”), a leading early-stage life science accelerator and investment firm, today announced that its portfolio company, Lodo Therapeutics Corporation ("Lodo" or the "Company"), has been acquired by Zymergen Inc. (NASDAQ: ZY) for an undisclosed amount.

• WELL's CRH Medical Acquires Majority Stake in Two Anesthesia Practices

  5/27/2021

  WELL Health Technologies Corp. is pleased to announce its wholly owned subsidiary, CRH Medical Corporation, has completed two accretive transactions whereby the company has acquired a 51% stake in Northern Indiana Anesthesia Associates, LLC and an add-on practice in Bradenton, Florida which will be part of CRH affiliate, FDHS Anesthesia, LLC.

• Olympus Acquires Israeli Medical Device Company Medi-Tate to Drive Global Urology Business Growth

  5/27/2021

  Olympus Corporation (”Olympus” – Director, Representative Executive Officer, President and CEO: Yasuo Takeuchi) announced today that it has finalized the acquisition of Israeli medical device company Medi-Tate Ltd. (“Medi-Tate” – CEO: Ido Kilemnik) following the announcement of its decision to exercise the call option in February, 2021

• PharmaTher Collaborates with MediSynergics to Develop Patented Ketamine Formulation for Pain Disorders and to Discover Novel Psychedelic Formulations

  5/27/2021

  PharmaTher Holdings Ltd. (the “Company” or “PharmaTher”) (OTCQB: PHRRF) (CSE: PHRM), a clinical-stage psychedelics biotech company, is pleased to announce that it has entered into a collaboration agreement with MediSynergics, LLC.

• eFFECTOR Therapeutics and Locust Walk Acquisition Corp. Announce Merger Agreement to Create Publicly Listed, Next-Generation Oncology Company Developing New Class of Cancer Therapies

  5/27/2021

  Gross proceeds expected to include $60 million from a committed PIPE and up to $175 million held in trust Anticipated cash resources will fund eFFECTOR’s pipeline advancement through multiple clinical milestones Merger expected to be completed in third quarter of 2021; combined company expected to be listed on Nasdaq under the ticker “EFTR” 

• Akorn Announces Agreement to Sell its Consumer Health Business to Prestige Consumer Healthcare

  5/27/2021

  Akorn Operating Company LLC, a leading specialty pharmaceutical company, announced that it has entered into a definitive agreement to sell its Consumer Health business to an affiliate of Prestige Consumer Healthcare Inc. for a total enterprise value of $230 million, which will be paid in cash.

• Afya Limited Announces Entering into of Purchase Agreement for the Acquisition of UNIGRANRIO

  5/27/2021

  Afya Limited, or Afya (Nasdaq: AFYA) today announced it entered into a purchase agreement for the acquisition, through its wholly-owned subsidiary Afya Participações S.A., of 100% of the total share capital of Universidade do Grande Rio Professor José de Souza Herdy (“UNIGRANRIO”

• 

  Lyell Plans $150 Million IPO to Advance Cell Therapies for Solid Tumors

  5/26/2021

  The company, which isn’t expected to enter the clinic until possibly in 2022, is working to make cell therapies work in solid tumors.

• Novo Integrated Sciences Completes Acquisition of PRO-DIP, LLC

  5/26/2021

  Novo Integrated Sciences, Inc. (NASDAQ:NVOS) (the “Company” or “Novo”) announced today it has completed the acquisition of PRO-DIP, LLC, a U.S.-based company that has developed an innovative, patent-pending oral pouch delivery system technology which allows for broad market applications related to nutritionally focused products and medicinal based formulations